Cystatin C is correlated with mortality in patients with and without acute kidney injury
Open Access
- 25 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (10), 3096-3102
- https://doi.org/10.1093/ndt/gfp196
Abstract
Background. Recent research has shown cystatin C to predict mortality and cardiovascular morbidity independent of renal function. The aim of this study was to evaluate the prognostic value of cystatin C on mortality in adult general ICU patients with acute kidney injury (AKI). We later expanded the study and included patients without signs of AKI. Methods. A total of 845 ICU patients were analysed for cystatin C and classified according to the RIFLE criteria. Of these, 271 patients with either creatinine >150 μmol/l, urea >25 or anuria/oliguria entered the AKI cohort. The remaining 562 patients entered the non-AKI cohort. Both cohorts were divided into quartiles according to cystatin C at entry. In the non-AKI cohort, we split the highest cystatin C quartile into two. The relationship between the different cystatin C quartiles and mortality in patients with and without AKI was estimated by hazard ratios (HR) derived from the Cox proportional hazards regression model. Results. A relationship between cystatin C and mortality was found in patients with and without AKI, being stronger in patients without AKI. In AKI patients, the HR comparing cystatin C above and below the median more than doubled from the second year on compared to the first year follow-up. After exclusion of patients in the non-AKI cohort with ‘potential AKI’ (creatinine >100 μmol/l or urea > 20 mmol/l), the correlation between cystatin C levels and risk of death was strengthened. Conclusions. Cystatin C is correlated with mortality independently of renal function measured by creatinine in patients entering the general ICU.Keywords
This publication has 32 references indexed in Scilit:
- Patient and Kidney Survival by Dialysis Modality in Critically Ill Patients with Acute Kidney InjuryThe International Journal of Artificial Organs, 2007
- Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failureIntensive Care Medicine, 2007
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care UnitJournal of the American Society of Nephrology, 2005
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryThe Lancet, 2005
- Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteriaNephrology Dialysis Transplantation, 2004
- Minimal Changes of Serum Creatinine Predict Prognosis in Patients after Cardiothoracic SurgeryJournal of the American Society of Nephrology, 2004
- Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injuryKidney International, 2002
- Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive careIntensive Care Medicine, 2000
- Risk factors for acute renal failure in trauma patientsIntensive Care Medicine, 1998